ThinkGen Announces Collaboration With PharmaVOICE to Produce a Series of Monthly Therapeutic Category Publications
Sources:

ThinkGen, PharmaVOICE

January 16, 2020

Philadelphia, PA, (January 16, 2020)—ThinkGen, a leading global pharmaceutical market research and consultancy firm, announced it has partnered with PharmaVOICE to produce the magazine’s monthly Therapeutic Digest Series.

The first eBook, on gene therapy, was issued mid-January. The eBook style publication will be monthly and include content from a science perspective featuring the pipeline and products in specific therapeutics categories.

The eBook on Gene Therapy, www.pharmavoice.com/therapeutic-digests/age-gene-therapy/, explains what gene therapy is, its potential for revolutionizing medical treatments, and some of the issues being addressed in the development, manufacture and marketing of gene therapies. It provides a comprehensive description of the products being marketed and under development.

Upcoming eBook topics will be:

  • February – Mental Health
  • March – Neurodegenerative Diseases
  • April – Medical Cannabis
  • May – Diabetes/Metabolic
  • June – Infectious Diseases
  • July – Oncology
  • August – Cardiology
  • September – Digital Therapeutics
  • October – Women’s Health
  • November – Central Nervous System
  • December – Rare Disease

Noah Pines, ThinkGen’s CEO, said “ThinkGen is committed to leading the way in understanding and capturing how high value medical and therapeutic product markets are evolving. This collaboration with PharmaVOICE will yield a series of well-written and insightful resources highlighting new developments and providing expert viewpoints, trends and data in medically important therapeutic areas.”

PharmaVOICE is written and designed to deliver the views, opinions, and insights of executives who are shaping the direction of the dynamic life-sciences industry. PharmaVOICE reaches more than 46,000 BPA qualified subscribers and is distributed to 60,000 industry executives with the digital edition. The audience includes executives from pharmaceutical manufacturing, biotechnology, drug discovery, research & development, contract research, drug delivery, and device/diagnostic companies.

The publication also targets decision makers at healthcare advertising, marketing, medical education, public relations, information technology, contract sales, traditional and nontraditional media, and other service support companies and organizations.

Based in Philadelphia, PA, ThinkGen is a full-service market research and consultancy firm providing actionable insights to help its clients advance their businesses. ThinkGen is proud to be on the corporate council of NORD, the National Organization for Rare Disorders, and is a corporate partner of the Healthcare Businesswomen’s Association (HBA).

If you would like more information about this new series, please call Jane Jorgensen at 215-470-8005, or email, jane.jorgensen@think-gen.com.

PharmaVOICE contact: Taren Grom, Editor PharmaVOICE, tgrom@pharmavoice.com, 267-323-2118.

Post a Comment

You must be logged in to post a Comment.

FEEDBACK